Recipharm publishes Annual report 2016
Recipharm publishes today its 2016 Annual report. The report summarises the business and highlights for 2016 and gives insights into the company’s strategy.“We made significant progress on our strategic commitments during the year – including the expansion of our geographic footprint beyond our strong European base, and building on our public listing in 2014 to leverage international investment” says CEO Thomas Eldered in his statement. The report is attached through the link at the end of the press release and it is also presented on www.recipharm.com. To order a printed copy, please